Additional file 2: of Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions

Inari, Hitoshi; Suganuma, Nobuyasu; Kawachi, Kae; Yoshida, Tatsuya; Yamanaka, Takashi; Nakamura, Yoshiyasu; Yoshihara, Mitsuyo; Nakayama, Hirotaka; Yamanaka, Ayumi; Masudo, Katsuhiko; Oshima, Takashi; Yokose, Tomoyuki; Rino, Yasushi; Shimizu, Satoru; Miyagi, Yohei; Masuda, Munetaka

doi:10.6084/m9.figshare.c.3704494_D2.v1

12885_2017_3154_MOESM2_ESM.doc (52 kB)

Additional file 2: of Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions

journal contribution

posted on 2017-02-27, 05:00 authored by Hitoshi Inari, Nobuyasu Suganuma, Kae Kawachi, Tatsuya Yoshida, Takashi Yamanaka, Yoshiyasu Nakamura, Mitsuyo Yoshihara, Hirotaka Nakayama, Ayumi Yamanaka, Katsuhiko Masudo, Takashi Oshima, Tomoyuki Yokose, Yasushi Rino, Satoru Shimizu, Yohei Miyagi, Munetaka Masuda

Evaluation of immunostaining of EZH2 and Ki67. (DOC 52 kb)

Funding

the Platform of Supporting Cohort Study and Biospecimen Analysis

History

Usage metrics

Keywords

Metastatic breast cancer EZH2 Ki-67 Prognostic factor Immunohistochemistry Epigenetics

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2: of Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions

Funding

the Platform of Supporting Cohort Study and Biospecimen Analysis

History

Usage metrics

Categories

Keywords

Licence

Exports